[Biological effectiveness of fast neutrons with a mean energy of 22 MeV]

Area of Science:

• Radiobiology
• Nuclear Physics
• Radiation Oncology

Background:

• Neutron radiation therapy offers potential advantages due to its high linear energy transfer.
• Understanding the biological effectiveness of different neutron energies is critical for optimizing radiation treatments and ensuring radiation safety.

Purpose of the Study:

• To compare the biological effectiveness of 22 MeV fast neutrons with 1.2 MeV fission spectrum neutrons.
• To determine the relative biological effectiveness (RBE) of these neutron types using lethality and cell survival models.

Main Methods:

• Neutron irradiation of biological models using 22 MeV fast neutrons (generated via d[50 MeV]----Be reaction) and 1.2 MeV fission spectrum neutrons.
• Determination of LD50/30 (lethal dose for 50% of subjects within 30 days) for both neutron types.
• Assessment of RBE using LD50/30 and D37 (dose to reduce survival to 37%) from a cell model.

Main Results:

• 22 MeV fast neutrons exhibited substantially lower biological effectiveness compared to 1.2 MeV fission spectrum neutrons.
• The LD50/30 for fission spectrum neutrons was 2.57 ± 0.07 Gy, while for 22 MeV fast neutrons it was 4.79 ± 0.13 Gy.
• The RBE coefficient was 1.34 ± 0.05 (based on LD50/30) and 1.5 ± 0.1 (based on D37 cell model).

Conclusions:

• The biological effectiveness of 22 MeV fast neutrons is lower than that of 1.2 MeV fission spectrum neutrons.
• The RBE values indicate that higher energy neutrons are less biologically damaging per Gray than lower energy neutrons.
• These findings have implications for neutron therapy planning and radiation protection protocols.